UCB Pharmaceuticals to Present Signals Analytics' Findings at Pharma CI Feb 18-19 2016 in Paris


UCB's Director of Intelligence Heresh Revazandi will be presenting at Pharma CI the impact of Signals' findings in reshaping UCB's approach to innovation beyond-the-pill and patient experience. The presentation will cover Signals insights on packaging, reformulation, and analysis on patient segmentation and journey.